Atreca (FRA:0C1) Machinery, Furniture, Equipment : €0.81 Mil (As of Sep. 2023)

View and export this data going back to 2019. Start your Free Trial

What is Atreca Machinery, Furniture, Equipment?

Atreca's Machinery, Furniture, Equipment for the quarter that ended in Sep. 2023 was €0.81 Mil.

Atreca's quarterly Machinery, Furniture, Equipment declined from Mar. 2023 (€3.26 Mil) to Jun. 2023 (€3.24 Mil) and declined from Jun. 2023 (€3.24 Mil) to Sep. 2023 (€0.81 Mil).

Atreca's annual Machinery, Furniture, Equipment increased from Dec. 2020 (€0.95 Mil) to Dec. 2021 (€2.95 Mil) and increased from Dec. 2021 (€2.95 Mil) to Dec. 2022 (€3.25 Mil).

Atreca Machinery, Furniture, Equipment Historical Data

The historical data trend for Atreca's Machinery, Furniture, Equipment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Atreca Machinery, Furniture, Equipment Chart

Atreca Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Machinery, Furniture, Equipment

Get a 7-Day Free Trial

0.85

0.91

0.95

2.95

3.25

Atreca Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Machinery, Furniture, Equipment	Get a 7-Day Free Trial															3.50	3.25	3.26	3.24	0.81

Atreca Machinery, Furniture, Equipment Calculation

Machinery, Furniture, Equipment represents those fixed assets specifically dealing with tools, equipment and office furniture.

Atreca (FRA:0C1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Atreca Inc (FRA:0C1) » Definitions » Machinery, Furniture, Equipment

Comparable Companies

Traded in Other Exchanges

BCEL:USA 0C1:Germany

Address

835 Industrial Road, Suite 400, San Carlos, CA, USA, 94070

Website

https://www.atreca.com

Atreca Inc is a biopharmaceutical company utilizing its differentiated platform to discover and develop novel antibody-based immunotherapeutics to treat a range of solid tumor types. It has single segment business of therapeutic drug discovery and development. The company's product candidate, ATRC-101, is a monoclonal antibody in preclinical development with a novel mechanism of action and target derived from an antibody identified using its discovery platform.

Atreca (FRA:0C1) Headlines

No Headlines